NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01777152,ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas,https://clinicaltrials.gov/study/NCT01777152,ECHELON-2,COMPLETED,"This is a double-blind, randomized, multicenter, phase 3 clinical trial to compare the efficacy and safety of brentuximab vedotin in combination with CHP with the standard-of-care CHOP in patients with CD30-positive mature T-cell lymphomas.",YES,Anaplastic Large-Cell Lymphoma|Non-Hodgkin Lymphoma|T-Cell Lymphoma,DRUG: brentuximab vedotin|DRUG: doxorubicin|DRUG: prednisone|DRUG: vincristine|DRUG: cyclophosphamide,"Progression-free Survival Per Independent Review Facility (IRF), The time from the date of randomization to the date of first documentation of progressive disease (PD), death due to any cause, or receipt of subsequent anticancer chemotherapy to treat residual or progressive disease whichever occurred first., Up to 60 months","Progression-free Survival Per IRF in Patients With Systemic Anaplastic Large Cell Lymphoma (sALCL), The time from the date of randomization to the date of first documentation of progressive disease (PD), death due to any cause, or receipt of subsequent anticancer chemotherapy to treat residual or progressive disease whichever occurred first., Up to 60 months|Complete Remission (CR) Rate Per IRF at End of Treatment (EOT), The count of participants with CR per IRF following the completion of study treatment (at end of treatment or at the first assessment after the last dose of study treatment and prior to long-term follow-up) according to the Revised Response Criteria for Malignant Lymphoma., Up to 8.34 months|Overall Survival (OS), The time from randomization to death due to any cause., Up to 90 months|Objective Response Rate (ORR) Per IRF at End of Treatment, The count of participants with CR or partial response (PR) per IRF following the completion of study treatment (at end of treatment or the first assessment after the last dose of study treatment and prior to long-term follow-up) according to the Revised Response Criteria for Malignant Lymphoma., Up to 8.34 months|Incidence of Adverse Events (AEs), Any untoward medical occurrence in a clinical investigational participant administered a medicinal product which does not necessarily have a causal relationship with this treatment., Up to 8.28 months|Incidence of Laboratory Abnormalities, Number of participants who experienced a Grade 3 or higher laboratory toxicity., Up to 8.28 months",,Seagen Inc.,"Millennium Pharmaceuticals, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE3,452,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",SGN35-014|2012-002751-42,2013-01-31,2018-08-15,2020-10-02,2013-01-28,2019-07-30,2021-11-30,"Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|City of Hope National Medical Center, Duarte, California, 91010-3000, United States|Stanford Cancer Center, Stanford, California, 94305, United States|Shands Cancer Center / University of Florida, Gainesville, Florida, 32610, United States|Orlando Health, Inc., Orlando, Florida, 32806, United States|University of Illinois at Chicago, Chicago, Illinois, 60612, United States|Cardinal Bernardin Cancer Center / Loyola University Medical Center, Maywood, Illinois, 60153, United States|Holden Comprehensive Cancer Center / University of Iowa, Iowa City, Iowa, 52242, United States|University of Kansas Cancer Center, Westwood, Kansas, United States, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Memorial Sloan Kettering Cancer Center - Basking Ridge, Basking Ridge, New Jersey, 07920, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Albert Einstein Cancer Center, Bronx, New York, 10461, United States|Montefiore Medical Center, Bronx, New York, 10467, United States|Memorial Sloan Kettering Cancer Center - Commack, Commack, New York, 11725, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10021, United States|Columbia University Medical Center, New York, New York, 10022, United States|Weill Cornell Medical College, New York, New York, 10065, United States|James P. Wilmot Cancer Center / University of Rochester Medical Center, Rochester, New York, 14642, United States|Jewish Hospital, The, Cincinnati, Ohio, 45236, United States|Cleveland Clinic, The, Cleveland, Ohio, 44195, United States|Mercy Clinic Oncology, Oklahoma City, Oklahoma, 73120, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 30384, United States|Charles A. Sammons Cancer Center / Baylor University Medical Center, Dallas, Texas, 75246, United States|MD Anderson Cancer Center / University of Texas, Houston, Texas, 77030-4095, United States|University of Virginia, Charlottesville, Virginia, 22908, United States|Virginia Commonwealth University Medical Center, Richmond, Virginia, 23298, United States|Benaroya Research Institute/Virginia Mason Medical Center, Seattle, Washington, 98101, United States|Seattle Cancer Care Alliance / University of Washington, Seattle, Washington, 98109-1023, United States|Royal Adelaide Hospital, Adelaide, 5000, Australia|Moorabbin Hospital, Bentleigh East, 3165, Australia|Icon Cancer Care Chermside, Chermside, 4032, Australia|Icon Cancer Care South Brisbane, Chermside, 4032, Australia|Icon Cancer Care Southport, Chermside, 4032, Australia|Icon Cancer Care Wesley, Chermside, 4032, Australia|Monash Medical Centre, Clayton, 3168, Australia|Concord Repatriation General Hospital, Concord, 2139, Australia|St. Vincent's Hospital Sydney, Darlinghurst, 2010, Australia|St Vincent's Public Hospital Sydney - Fitzroy, Fitzroy, 3065, Australia|Western Hospital, Footscray, 3011, Australia|Austin Health, Heidelberg, 3084, Australia|Calvary Mater Newcastle, Waratah, 2298, Australia|McGill University Department of Oncology / McGill University Health Centre, Montreal, H3H 2R9, Canada|Jewish General Hospital, Montreal, H3T 1E2, Canada|Sunnybrook Health Sciences Centre, Toronto, M4N 3M5, Canada|British Columbia Cancer Agency - Vancouver Centre, Vancouver, V5Z 4E6, Canada|Fakultni nemocnice Brno, Brno, 625 00, Czechia|Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie, Hradec Kralove, 500 05, Czechia|Fakultni Nemocnice Ostrava, Ostrava - Poruba, 708 52, Czechia|Fakultni Nemocnice Kralovske Vinohrady, Praha 10, 100 34, Czechia|Vseobecna fakultni nemocnice v Praze, Praha 2, 128 08, Czechia|Aarhus University Hospital, Aarhus C., 8000, Denmark|Rigs Hospiltalet, Copenhagen, DK 2100, Denmark|Odense University Hospital, Odense C, 5000, Denmark|Hôpital Henri Mondor, Créteil, 94010, France|CHD Vendée, Site de La Roche-sur-Yon, Les Oudairies, La Roche-sur-Yon Cedex 9, 85925, France|Centre Hospitalier Universitaire de Grenoble, La Tronche, 38700, France|Clinique Victor Hugo, Le Mans, 72000, France|CHRU de Lille, Lille cedex, 59037, France|Centre Hospitalier Universitaire (CHU) De Limoges - Hopital Dupuytren, Limoges Cedex, 87042, France|Centre Hospitalier Universitaire Nantes-Hotel Dieu, Nantes cedex 1, 44093, France|Hopital Saint-Louis / Service d'Hematologie, Paris Cedex 10, 75475, France|Groupe Hospitalier Pitié-Salpétrière, Paris, 75013, France|Groupe Hospitalier du Haut Leveque, Pessac, 33604, France|Centre Hospitalier Lyon Sud, Pierre Bénite Cedex, 69495, France|Centre Hospitalier Universitaire de Poitiers, Poitiers Cedex, 86021, France|Centre Hospitalier Universitaire de Rennes, Hopital Pontchaillou, Rennes Cedex 9, 35033, France|Centre Henri Becquerel / Centre Regional de Lutte Contre le Cancer, Rouen, 76038, France|Charite Universitatsmedizin Berlin, Berlin, 10117, Germany|Charite Campus Benjamin Franklin, Berlin, 12203, Germany|Klinikum Chemnitz gGmbH, Chemnitz, 09113, Germany|Universitatsklinikum Essen, Essen, 45122, Germany|Krankenhaus Nordwest GmbH, Frankfurt am Main, 60488, Germany|Georg-August-Universität Göttingen, Göttingen, 37075, Germany|Universitätsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitätsklinikum des Saarlandes, Homburg/Saar, 66421, Germany|Klinik für Innere Medizin II, Friedrich-Schiller-Universität, Jena, 07747, Germany|Universitatsklinikum Koln, Köln, 50937, Germany|Klinikum der Ludwig-Maximilians-Universität München, München, 81377, Germany|Klinikum Nürnberg, Nürnberg, 90419, Germany|Universitätsklinikum Ulm, Ulm, 89081, Germany|Semmelweis Egyetem, Budapest, 1083, Hungary|Debreceni Egyetem, Debrecen, 4032, Hungary|Somogy Megyei Kaposi Mór Oktató Kórház, Kaposvár, 7400, Hungary|Markusovszky Egyetemi Oktatokorhaz, Szombathely, 9700, Hungary|Soroka Medical Center, Dept. of Oncology, Beer Sheva, 84101, Israel|Rambam Health Corp., Haifa, 31096, Israel|Hadassah Medical Center, Jerusalem, 91120, Israel|Rabin Medical Center, Petach Tikva, 49414, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel|Azienda Ospedaliera SS. Antonio E. Biagio E. Cesare Arrigo di Alessandria, Alessandria, 15121, Italy|Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, 24127, Italy|Instituto di Ematologia ed Oncologia Medica, Bologna, 40138, Italy|Azienda Ospedaliera Spedali Civili di Brescia, Brescia, 25123, Italy|Azienda Ospedaliera-Universitaria Vittorio Emanuele-Ferrarotto-Santo Bambino, Catania, 95124, Italy|Azienda Ospedaliera Universitaria San Martino, Genova, 16132, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Ospedale Niguarda Ca' Granda, Milano, 20162, Italy|IRCSS Policlinico San Matteo, Pavia, 27100, Italy|Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, 61100, Italy|Università degli Studi di Roma ""La Sapienza, Policlinico Umberto I, Roma, 00161, Italy|Istituto Clinico Humanitas-Humanitas Cancer Center, Rozzano, 20089, Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, 10126, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, 37134, Italy|Keimyung University Dongsan Medical Center, Daegu, 700-712, Korea, Republic of|Chonnam National University Hwasun Hospital, Hwasun, 519-763, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, 463-707, Korea, Republic of|Seoul National University Hospital, Seoul, 110-744, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, 120-752, Korea, Republic of|Samsung Medical Center, Seoul, 135-710, Korea, Republic of|Seoul Saint Mary's Hospital, Seoul, 137-701, Korea, Republic of|Asan Medical Center, Seoul, 138-876, Korea, Republic of|Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza, Brzozow, 36-200, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich, Chorzów, 41-500, Poland|Malopolskie Centrum Medyczne S.C., Krakow, 30-510, Poland|Centrum Onkologii Institut im. Marii Sklodowskiej-Curie, Warsaw, 02-781, Poland|Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu, Bucharest, 022328, Romania|Spitalul Clinic Coltea, Bucuresti, 030171, Romania|Institutul Oncologic ""Prof. Dr. I. Chiricuta"" Cluj-Napoca, Cluj-Napoca, 400015, Romania|Spitalul Clinic Judetean de Urgenta Targu Mures, Sectia Clinica Hematologie si Transplant Medular, Targu Mures, 540136, Romania|Hospital de la Santa Creu i Sant Paul, Barcelona, 08025, Spain|Institut Universitari Dexeus, Barcelona, 08028, Spain|Institut Català D'oncologia, L'Hospitalet de Llobregat, 08907, Spain|Hospital de León, León, 24071, Spain|Hospital General Universitario Gregorio Marañon, Madrid, 28007, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Puerta de Hierro Majadahonda, Majadahonda, 28222, Spain|Hospital Universitaro de Salamanca, Salamanca, 37007, Spain|Hospital Universitario Virgen del Rocio, Sevilla, 41013, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, 46026, Spain|Chang Gung Memorial Hospital - Kaohsiung, Kaohsiung, 83301, Taiwan|China Medical University Hospital, Taichung, 404, Taiwan|National Cheng-Kung University Hospital, Tainan, 70403, Taiwan|Chang Gung Memorial Hospital - Taoyuan, Taoyuan, 33305, Taiwan|Addenbrooke's Hospital, Cambridge, CB2 0QQ, United Kingdom|University Hospitals of Leicester NHS Trust, Leicester, LE1 5WW, United Kingdom|Saint George's Hospital NHS Trust, London, SW17 0RE, United Kingdom|Christie Hospital NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|Freeman Hospital, Newcastle upon Tyne, NE7 7DN, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, NG5 1PD, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/52/NCT01777152/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/52/NCT01777152/SAP_001.pdf"
